Raquel Jex Forsgren

Raquel Jex Forsgren currently serves as Chief of Strategy at BluPrint Oncology, where responsibilities include overseeing corporate strategy, client strategy development, and leading high-stakes projects. Raquel has a diverse background, previously holding positions such as Senior Vice President of Client Services at BluPrint Oncology and Founder of Front-Line Resilience Health, LLC. Raquel's extensive experience in oncology includes roles at AbbVie, NeurogesX, BioLumina, Biogen Idec, Novartis, Pfizer, and Lockheed Martin, with expertise spanning various cancers and conditions. Educational credentials include a Master of Science in Pharmacology and a Bachelor's degree in Biology with a minor in Microbiology from Idaho State University.